Analysis of dihydrofolate reductase and reduced folate carrier gene status in relation to methotrexate resistance in osteosarcoma cells-Reference-Cited by-同舟云学术

Analysis of dihydrofolate reductase and reduced folate carrier gene status in relation to methotrexate resistance in osteosarcoma cells

Published:2004-01 Issue:1 Volume:15 Page:151-160
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Serra M.,Reverter-Branchat G.,Maurici D.,Benini S.,Shen J.-N.,Chano T.,Hattinger C.-M.,Manara M.-C.,Pasello M.,Scotlandi K.,Picci P.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/15/1/151/332120/mdh004.pdf

Reference33 articles.

1. Prognostic factor in osteosarcoma: a critical review;Davis;J Clin Oncol,1994

2. Adjuvant chemotherapy of high-grade osteosarcoma of the extremity: updated results of the Multi-Institutional Osteosarcoma Study;Link;Clin Orthop,1991

3. Prognostic factors in bone sarcomas;Saeter;Acta Orthop Scand Suppl,1997

4. Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities;Bacci;Cancer,1993

5. The role of chemotherapy in the management of non-metastatic operable extremity osteosarcoma;Bramwell;Semin Oncol,1997

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vivo therapy of osteosarcoma using anion transporters-based supramolecular drugs;Journal of Nanobiotechnology;2024-01-13

2. Single-nucleotide polymorphism profiling by multimodal-targeted next-generation sequencing in methotrexate-resistant and -sensitive human osteosarcoma cell lines;Frontiers in Pharmacology;2023-11-22

3. Dual-drug codelivery nanosystems: An emerging approach for overcoming cancer multidrug resistance;Biomedicine & Pharmacotherapy;2023-05

4. miR-197-3p Promotes Osteosarcoma Stemness and Chemoresistance by Inhibiting SPOPL;Journal of Clinical Medicine;2023-02-01

5. The strategy and clinical relevance of in vitro models of MAP resistance in osteosarcoma: a systematic review;Oncogene;2022-11-25